This September, the American Cancer Society encourages men to talk with their doctor about their personal risk for prostate cancer and whether screening is right for them. The number of new cases continued to increase by 3% per year from 2014 to 2022, according to the American Cancer Society’s Cancer Statistics 2026 report, with the steepest rise occurring in advanced-stage diagnoses.
The report estimates that in 2026, 333,830 new cases of prostate cancer will be diagnosed in the U.S. and 36,320 men will die from the disease. The increase in prostate cancer diagnoses is largely due to more men being screened. This creates opportunities for early intervention and improved patient outcomes, although too many men are still not being screened early enough.
“We’re seeing two things happen at once: more men are being diagnosed with prostate cancer, and a growing share of those cases are happening at a more advanced stage,” said Dr. William Dahut, chief scientific officer at the American Cancer Society. “That tells us screening conversations are happening too late for too many men, particularly those at high risk for the disease.”
There are well-established risk factors for prostate cancer that can be assessed for free using the online tool ACS CancerRisk360TM. The chance of having prostate cancer rises rapidly after age 50, and the disease occurs more often in Black and Caribbean men. When it does develop in Black men, they tend to be younger. In fact, compared with White men, Black men are nearly 70% more likely to be diagnosed with prostate cancer and two times more likely to die from the disease.
When it comes to prostate cancer screening, one size does not fit all. The American Cancer Society recommends men at average risk for prostate cancer speak with their doctor at age 50 about whether screening is right for them. Men at high risk should have this discussion at age 45, including African American men and those with a family history of prostate cancer.
